about
Axonal transport disruption in peripheral nerve disease: From Jack's discoveries as a resident to recent contributionsA novel pathogenesis of megacolon in Ncx/Hox11L.1 deficient miceTargeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal deathDiffusion tensor imaging detects corticospinal tract involvement at multiple levels in amyotrophic lateral sclerosis.Local synthesis of dynein cofactors matches retrograde transport to acutely changing demandsThe Intersection of NGF/TrkA Signaling and Amyloid Precursor Protein Processing in Alzheimer's Disease NeuropathologyA simple test to monitor the motor dysfunction in a transgenic mouse model of amyotrophic lateral sclerosisKinesin molecular motors: transport pathways, receptors, and human disease.JNK regulates FoxO-dependent autophagy in neuronsAutophagy failure in Alzheimer's disease--locating the primary defect.Polymorphisms of GSTT1, GSTM1, and EPHX genotypes in patients with cryptogenic polyneuropathy: a case-control study.1-Methyl-4-phenylpyridinium affects fast axonal transport by activation of caspase and protein kinase CReduced neurofilament expression in cutaneous nerve fibers of patients with CMT2E.Spontaneous murine neuroaxonal dystrophy: a model of infantile neuroaxonal dystrophy.Measuring vibration threshold with a graduated tuning fork in normal aging and in patients with polyneuropathy. European Inflammatory Neuropathy Cause and Treatment (INCAT) group.Targeting caspase-6 and caspase-8 to promote neuronal survival following ischemic stroke.Impaired NGF/TrkA Signaling Causes Early AD-Linked Presynaptic Dysfunction in Cholinergic Primary NeuronsSynaptic failure and α-synuclein.Therapeutic strategies for the inherited neuropathies.A role for neurofilaments in the pathogenesis of amyotrophic lateral sclerosis.Node-paranode regions as local degradative centres in alpha-motor axons.Intracellular deposition, microtubule destabilization, and transport failure: an "early" pathogenic cascade leading to synaptic decline.Extracellular truncated tau causes early presynaptic dysfunction associated with Alzheimer's disease and other tauopathiesEffects of perinatal asphyxia on rat striatal cytoskeleton.Microstructural integrity of cerebral fiber tracts in hereditary spastic paraparesis with SPG11 mutation.Neurofilament proteolysis after focal ischemia; when do cells die after experimental stroke?Alterations of a 200 kDa neurofilament in the rat hippocampus after forebrain ischemia.Intrathecal vincristine: fatal myeloencephalopathy despite cerebrospinal fluid perfusion.Neostriatal cytoskeleton changes following perinatal asphyxia: effect of hypothermia treatment.Evidence for direct axonal toxicity in vincristine neuropathy.Impaired Neurofilament Integrity and Neuronal Morphology in Different Models of Focal Cerebral Ischemia and Human Stroke Tissue.Tracing Axons of Peripheral Nerves in Rats: A Potential Technique to Study the Equine Recurrent Laryngeal NerveRepetitive Nerve Stimulation in Amyotrophic Lateral Sclerosis
P2860
Q26865470-9E72C3A6-E6C3-4E2C-B0E5-09CDF32FF6C2Q28510532-6B1B528E-ECB1-4D27-B22B-7E379925F930Q28587075-6E1541B2-5867-400E-9D9B-C93D07059BE3Q30819980-51E8AA8E-91AD-48E3-ADC6-F5D355654D97Q30833108-D4901F64-16E0-440F-9B00-E0FCF108227AQ33839157-A5AEA087-D8D9-474B-A548-A261FD1DBA38Q33921524-6AF3A41F-6085-4566-B929-88E11B645E50Q34287420-1C91A248-0F32-4CCA-9E37-C907F6534C1EQ34588421-3FD74D06-34E7-4F2B-BFF5-09012E684662Q34987827-45A3E981-8D75-4BD8-97A2-F9FEF5058965Q35609321-914EF367-160E-4C22-B68E-CBB1DC740089Q35844553-AE652D42-27C8-401E-9181-689D27B88EBEQ35892764-C7C152AC-95B9-4349-8E0F-806225DF84D7Q36177182-BE6043F7-9A85-4F1D-8759-38F84760F5DCQ36319055-F918735D-8AAF-42B0-AD32-ED269228CE69Q36349902-AC98E451-6531-4A8A-9B89-DD288DBD86D6Q37699616-A14BD3D2-13FE-491C-B621-AA5EFB9034EAQ38704236-1A1439A8-5630-43CA-A259-ACD5B3E4CF9BQ40316169-1A1E2478-4DF5-444E-9527-66F83697D1A0Q41037886-A5BD613C-9458-44ED-82FF-818152B649ACQ41140026-12C7A95F-819D-48BD-B34F-67C769E8A7A8Q41917203-601B4E2C-AA53-4052-A8CE-5FCE2A513076Q42371467-062DA784-D58F-4E6B-91A1-08D1EBA075D6Q44888669-16E4B45C-0DC4-401F-BE73-EC0961811FA4Q45766373-DBFBAEE8-DBAF-47DE-845B-18C3FAE2CCF5Q48188958-906501D4-4280-489A-905B-801ADB61B5D4Q48300253-092933CA-4A1C-42CF-A834-08C7D517BFEDQ48491786-8C4A09E6-FEFB-4569-A17D-8FE308C1EF7EQ48509787-FC1E6790-1037-417A-B011-940E968926CFQ51141377-9A36CA35-63B3-4F3D-BAFB-3B3E0352030FQ55412964-1BAFEA21-6E71-40B1-9431-E70DCB5F262DQ58277110-8B04154E-6AED-4E8C-A723-31DCE8E42658Q58714179-31318721-C7D3-4DAC-9430-156A0C4D0DA6
P2860
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Axonal transport in neurological disease.
@en
Axonal transport in neurological disease.
@nl
type
label
Axonal transport in neurological disease.
@en
Axonal transport in neurological disease.
@nl
prefLabel
Axonal transport in neurological disease.
@en
Axonal transport in neurological disease.
@nl
P2860
P356
P1433
P1476
Axonal transport in neurological disease.
@en
P2093
P2860
P356
10.1002/ANA.410230103
P577
1988-01-01T00:00:00Z